A

Abeona Therapeutics
D

ABEO

5.14000
USD
-0.05
(-0.87%)
مغلق
حجم التداول
5,997
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
223,441,094
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    E
    EDIT
    0.15000
    (12.50%)
    1.35000 USD
    N
    NTLA
    1.040
    (10.45%)
    10.990 USD
    Q
    QURE
    0.390
    (2.61%)
    15.310 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    R
    RGNX
    0.28500
    (3.77%)
    7.85000 USD
    S
    SGMO
    0.03500
    (3.13%)
    1.15500 USD
    V
    VYGR
    0.22000
    (4.21%)
    5.45000 USD
    المزيد
الأخبار
المقالات

العنوان: Abeona Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.